J. S. Lee

2.3k total citations · 1 hit paper
20 papers, 1.8k citations indexed

About

J. S. Lee is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, J. S. Lee has authored 20 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 10 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in J. S. Lee's work include Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Research Studies (5 papers) and Retinoids in leukemia and cellular processes (4 papers). J. S. Lee is often cited by papers focused on Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Research Studies (5 papers) and Retinoids in leukemia and cellular processes (4 papers). J. S. Lee collaborates with scholars based in United States, South Korea and Canada. J. S. Lee's co-authors include W. K. Hong, Frank V. Fossella, Jack A. Roth, Joe B. Putnam, E. Neely Atkinson, R. Komaki, Hari M. Dhingra, Martin Chasen, Michael Ryan and Malcolm H. McGavran and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Oncogene and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

J. S. Lee

19 papers receiving 1.7k citations

Hit Papers

A Randomized Trial Comparing Perioperative Chemotherapy a... 1994 2026 2004 2015 1994 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. S. Lee United States 15 1.2k 728 354 214 192 20 1.8k
Christian Nicolaj Andreassen Denmark 18 583 0.5× 307 0.4× 537 1.5× 945 4.4× 96 0.5× 33 1.5k
Laurence Goethals Belgium 16 247 0.2× 237 0.3× 176 0.5× 141 0.7× 127 0.7× 25 832
Dolores Gallardo‐Rincón Mexico 18 275 0.2× 524 0.7× 494 1.4× 116 0.5× 165 0.9× 49 1.3k
Cheng–Lung Hsu Taiwan 17 296 0.3× 284 0.4× 307 0.9× 237 1.1× 204 1.1× 33 1.2k
Lye Mun Tho Malaysia 15 315 0.3× 780 1.1× 869 2.5× 113 0.5× 173 0.9× 33 1.6k
Yaping Xu China 19 495 0.4× 411 0.6× 317 0.9× 143 0.7× 233 1.2× 63 1.1k
T. Smudzin United States 15 563 0.5× 184 0.3× 173 0.5× 516 2.4× 102 0.5× 34 1.4k
Josephine A. Ratikan United States 11 316 0.3× 641 0.9× 374 1.1× 328 1.5× 75 0.4× 16 1.3k

Countries citing papers authored by J. S. Lee

Since Specialization
Citations

This map shows the geographic impact of J. S. Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. S. Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. S. Lee more than expected).

Fields of papers citing papers by J. S. Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. S. Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. S. Lee. The network helps show where J. S. Lee may publish in the future.

Co-authorship network of co-authors of J. S. Lee

This figure shows the co-authorship network connecting the top 25 collaborators of J. S. Lee. A scholar is included among the top collaborators of J. S. Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. S. Lee. J. S. Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Seviour, Elena G., Vishal Sehgal, Dhruva K. Mishra, et al.. (2016). Targeting KRas-dependent tumour growth, circulating tumour cells and metastasis in vivo by clinically significant miR-193a-3p. Oncogene. 36(10). 1339–1350. 38 indexed citations
2.
Bae, Yun Jung, Kangjin Jeong, Sun Young Rha, et al.. (2014). hTERT mediates norepinephrine-induced Slug expression and ovarian cancer aggressiveness. Oncogene. 34(26). 3402–3412. 66 indexed citations
3.
Lenzi, Renato, Frank V. Fossella, & J. S. Lee. (2011). Systemic Treatment of Non-Small Cell Lung Cancer. Oxford University Press eBooks. 18(3). 27–30.
4.
Hittelman, Walter N., D. D. Liu, Jonathan M. Kurie, et al.. (2007). Proliferative Changes in the Bronchial Epithelium of Former Smokers Treated With Retinoids. JNCI Journal of the National Cancer Institute. 99(21). 1603–1612. 14 indexed citations
5.
Belani, Chandra P., J. S. Lee, Mark A. Socinski, et al.. (2005). Randomized phase III trial comparing cisplatin–etoposide to carboplatin–paclitaxel in advanced or metastatic non-small cell lung cancer. Annals of Oncology. 16(7). 1069–1075. 106 indexed citations
6.
Hong, Eun Kyoung, et al.. (2005). Thymidine phosphorylase expression in tumour cells and tumour response to capecitabine plus docetaxel chemotherapy in non-small cell lung cancer. Journal of Clinical Pathology. 58(6). 650–654. 24 indexed citations
7.
Komaki, Ritsuko, Wendy Seiferheld, David S. Ettinger, et al.. (2002). Randomized phase II chemotherapy and radiotherapy trial for patients with locally advanced inoperable non-small-cell lung cancer: long-term follow-up of RTOG 92-04. International Journal of Radiation Oncology*Biology*Physics. 53(3). 548–557. 55 indexed citations
8.
Lee, J. Jack, D. Liu, J. S. Lee, et al.. (2001). Long-Term Impact of Smoking on Lung Epithelial Proliferation in Current and Former Smokers. JNCI Journal of the National Cancer Institute. 93(14). 1081–1088. 81 indexed citations
9.
Lee, J. S., Ritsuko Komaki, Jae Y. Ro, et al.. (1999). A pilot clinical laboratory trial of paclitaxel and endobronchial brachytherapy in patients with non-small cell lung cancer.. PubMed. 9(2 Suppl 1). 121–9. 7 indexed citations
10.
Mao, Li, V. Papadimitrakopoulou, Dong M. Shin, et al.. (1998). Phenotype and Genotype of Advanced Premalignant Head and Neck Lesions After Chemopreventive Therapy. JNCI Journal of the National Cancer Institute. 90(20). 1545–1551. 122 indexed citations
11.
Byhardt, Roger W., Charles Scott, William T. Sause, et al.. (1998). Response, toxicity, failure patterns, and survival in five radiation therapy oncology group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non–small-cell carcinoma of the lung. International Journal of Radiation Oncology*Biology*Physics. 42(3). 469–478. 177 indexed citations
12.
Shin, Dong M., Scott M. Lippman, J. Jack Lee, et al.. (1997). Accumulation of p53 protein and retinoic acid receptor beta in retinoid chemoprevention.. PubMed. 3(6). 875–80. 30 indexed citations
13.
Lee, J. S., K. M. W. Pisters, Ritsuko Komaki, et al.. (1997). Paclitaxel/carboplatin chemotherapy as primary treatment of brain metastases in non-small cell lung cancer: a preliminary report.. PubMed. 24(4 Suppl 12). S12–52. 16 indexed citations
14.
Xu, Xiaochun, Maija H. Zile, Scott M. Lippman, et al.. (1995). Anti-retinoic acid (RA) antibody binding to human premalignant oral lesions, which occurs less frequently than binding to normal tissue, increases after 13-cis-RA treatment in vivo and is related to RA receptor beta expression.. PubMed. 55(23). 5507–11. 45 indexed citations
15.
Dhingra, Kapil, Nour Sneige, Tej K. Pandita, et al.. (1994). Quantitative analysis of chromosome in situ hybridization signal in paraffin‐embedded tissue sections. Cytometry. 16(2). 100–112. 31 indexed citations
16.
Roth, Jack A., Frank V. Fossella, R. Komaki, et al.. (1994). A Randomized Trial Comparing Perioperative Chemotherapy and Surgery With Surgery Alone in Resectable Stage IIIA Non-Small-Cell Lung Cancer. JNCI Journal of the National Cancer Institute. 86(9). 673–680. 804 indexed citations breakdown →
17.
Shin, Dong M., Narin Voravud, Jae Y. Ro, et al.. (1993). Sequential Increases in Proliferating Cell Nuclear Antigen Expression in Head and Neck Tumorigenesis: A Potential Biomarker. JNCI Journal of the National Cancer Institute. 85(12). 971–978. 136 indexed citations
18.
Lee, J. S., H I Libshitz, Frank V. Fossella, et al.. (1992). Improved Therapeutic Index by Leucovorin of Edatrexate, Cyclophosphamide, and Cisplatin Regimen for Non-Small-Cell Lung Cancer. JNCI Journal of the National Cancer Institute. 84(13). 1039–1040. 12 indexed citations
19.
Steck, Peter A., Gary E. Gallick, J. S. Lee, et al.. (1992). Suppression by retinoic acid of epidermal growth factor receptor autophosphorylation and glycosylation in cultured human head and neck squamous carcinoma cells.. PubMed. 101–10. 17 indexed citations
20.
Lippman, Scott M., Béla B. Toth, John G. Batsakis, et al.. (1990). Modulation by 13-cis retinoic acid of biologic markers as indicators of intermediate endpoints in human oral carcinogenesis.. PubMed. 339. 179–91. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026